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Introduction
Recent studies have shown that the pathogenesis of neurodegenerative diseases, such as Parkinson's disease (PD), Alzheimer's disease (AD) and Huntington's disease(HD), is closely associated with glial cells activation and peripheral immune cells infiltration, producing and releasing a large number of pro-inflammatory cytokines and chemokines [Ransohoff et al., 2015] . PD is associated with low levels cells, and it would decrease after synapses losing and can be seen in PD animal model [Fourie et al., 2014; Nash et al., 2005] . Tyrosine hydroxylase (TH), an important enzyme in the dopamine generation pathway, is associated with the occurrence of many neurogenic diseases, such as PD, schizophrenia, bipolar disorder and so on [Haavik et al., 1998; Kunugi et al., 1998 ].
Toll-like receptors (TLRs), a classic receptor for microglial activation, can recognize and bind with lipopolysaccharide (LPS) to activate microglia and initiate neuroinflammatory response by accelerating the production of pro-inflammatory cytokines [Qin et al., 2005; Qin et al., 2007] . In general sense, during the inflammatory progression, any endogenous factors, microbes or microbial products like LPS selectively bind with the upstream signaling molecules like TLR4, which further triggers the activation of another upstream adaptor protein molecule known as MyD88. Subsequently, MyD88 triggers the interleukin 1 receptor-associated kinases those involving the activation of several inflammatory mediated signaling events, specifically, NF-κB and mitogen-activated protein kinases (MAPK) signaling pathways, and contribute to the release of numerous inflammatory mediators like PGE 2 , COX-2, NO, iNOS, TNF-α, IL-1β, IL-6 and so on [Haque et al., 2018; Harikrishnan et al., 2018; Lu et al., 2008] . Therefore, NF-κB and MAPK signaling pathways play important roles in inflammatory response. Fig. 1) , a flavonoid compound isolated from the dry bark of Myrica rubra (Lour.) Siebold & Zucc, has been reported various bioactivities, such as anti-inflammatory activtity, anti-oxidative activity, and anti-fibrotic activity [Sun et al., 2013; Domitrović et al., 2015] . Our previous investigation have found myricitrin attenuated 6-OHDA-induced mitochondrial dysfunction and alleviated methylglyoxal-induced mitochondrial dysfunction Wang et al., 2014] . It is concluded that myricitrin might had a potential in treatment of PD.
Myricitrin (
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NeuN staining by Immunohistochemistry
After LPS administration, the mice were perfused with 0.1 M PBS and followed by 4% paraformaldehyde for immunofluorescence staining . Briefly, brain sections were mounted onto gelatin-coated coverslips and allowed to air dry.
Subsequently, after blocked and permeabilized, brain sections were incubated with anti-NeuN primary antibody (1:200) for overnight at 4℃. After washing with PBS, the brain sections were incubated with Cy3-conjugated secondary antibody for 2 h at room temperature. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) for 10 min at room temperature. Finally, cover-slips were mounted onto microscope slides and digital images were collected.
ELISA assay
The nigrostriatum tissues of mice were homogenized in coo l saline and centrifugated at 4500 rpm for 10 min at 4°C. The protein concentration of supernatant was quantified by BCA assay and the levels of IL-1β, IL-6, TNF-α, and MCP-1 in the supernatant were detected by ELISA kits according to manufacturer's instructions.
Briefly, 100μL of the supernatant samples and standards were added into each well of ELISA plate. Meantime, the biotinylated anti-mouse antibody solution was added to each well except for the blank control well, and incubated for 2 hour at 37°C. Then the plates were washed with wash buffer for 5 times. After washing, 100 μL of the HRP-streptavidin conjugated secondary antibody was added to each well and incubated for 60 min at 37°C. Subsequently, TMB solution was added and incubated at room temperature for 15 min. At last, stop solution was added to each well and absorbance at 450 nm was measured using a microplate reader. The cytokine concentration was determined using a standard curve. Cytokines level are expressed as pg of cytokines/mg total protein.
Western blot analysis
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The nigrostriatum tissues of mice were homogenized in cool RIPA buffer with the cocktail protease inhibitor and lysed on the ice for 30 min. Afterwards, the supernatant was collected and quantified by BCA assay. Proteins were separated by 10% SDS-PAGE gel and transferred on the PVDF membranes. The membranes were incubated in 5% BSA solution in order to occupy the nonspecific sites on the membranes at 37℃. Next, the membranes were incubated with anti-COX-2 antibody 1:1000), anti-Phospho-p38 (Rt, 1:1000) and anti-β-actin antibody respectively at 4 ℃ overnight. After horseradish peroxidase-conjugated secondary antibody incubation, the signal densities on the blots were measured using the enhanced ECL system and normalized using an internal control. The results from animals under various experiment conditions then were normalized by value of the corresponding control animal (fold change relative to control).
Real-Time PCR Analysis
TRIzol method was used to extract RNA as described previously [Cheng et al., 2018] . The nigrostriatum tissues of mice were prepared by homogenizer in cool Trizol.
Then, the supernatants were added 200 µL Chloroform and vortexed dramatically.
After centrifuging at 12, 000 g for 15 min at 4°C, the supernatants were collected and added 500 µL Isopropanol. After standing at room temperature for 30 min, the samples were centrifuged at 12, 000 g for 15 min at 4°C. After removing the supernatant, the precipitate was washed by 75% ethanol. Centrifuging at 12, 000 g for 5 min at 4°C, the supernatant was removed completely. Adding RNase free water into the pipes to fully dissolve RNA, the RNA was quantified by measuring the absorbance at 260 nm and 280 nm. Use the formula A260 × dilution × 40 = µg J o u r n a l P r e -p r o o f using the PrimeScript RT reagent kit. After RNA was reverse transcribed to cDNA, the cDNA was used to real-time PCR by using TransStart Top Green qPCR Super Relative quantitative analysis was determined using real-time SYBR green fluorescence and then calculated by the relative quantification of 2 -⊿⊿Ct method and using β-actin as internal reference.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 6.02 (GraphPad Software Inc., CA, USA) to compare the differences between each group. Data are expressed as the mean ± SD. Differences between the various groups were compared using one-way ANOVA and the Student-Newman-Keuls test, and p < 0.05 was considered as statistically significant.
Results

Myricitrin improved neuron morphology in nigrostriatum of LPS-stimulated mice
NeuN is a widely used marker for mature neurons expressed in nucleus and cell body of neurons. As compared to normal control, a clear decrease in NeuN staining was observed in LPS-stimulated mice, which may reflect of stunned or damaged cells were increased stimulated by LPS. However, after treatment with myricitrin 50 mg/kg, there was a increase in NeuN staining of nigrostriatum as compared to LPS-stimulated mice ( Fig. 2A and 2B ).
Myricitrin upregulated the expression of TH and PSD-95 in nigrostriatum of
LPS-stimulated mice
To further explore the protective effect of myricitrin on nigrostriatum, the levels of TH and PSD-95 in nigrostriatum were detected by WB assay. In LPS-stimulated group, the expression of TH and PSD-95 were both lower than that of in control group (both p < 0.01). However, myricitrin treatment at the doses of 20 mg/kg and 50 mg/kg both significantly improved the expression of TH (Fig 3A) and PSD-95 (Fig 3B) decreased by LPS injury. These data suggested that myricitrin could protect against nigrastriatum neuron injury by LPS.
Myricitrin decreased inflammatory factors and mediators in nigrostriatum of
LPS-stimulated mice
To evaluate the anti-inflammationary effects of myricitrin, the levels of IL-1β, IL-6, TNF-α and MCP-1 were assayed by ELISA. In LPS-stimulated group, the levels of IL-1β, IL-6, TNF-α, and MCP-1 were all increased in nigrostriatum tissues (all p<0.01). However, myricitrin at the doses of 25 and 50mg/kg both significantly decreased the levels of IL-1β (Fig. 4A ), IL-6 (Fig. 4B ), TNF-α (Fig. 4C) , and MCP-1 (Fig. 4D ) in nigrostriatum tissues. In addition, the levels of COX-2 and iNOS were determined by WB. The results showed that the expression of COX-2 and iNOS were increased in the LPS-stimulated group (both p < 0.01). Whereas, myricitrin at the doses of 20 mg/kg and 50 mg/kg treatment both significantly decreased the expressions of COX-2 ( Fig. 5A ) and iNOS (Fig. 5B ).
Myricitrin down-regulated TLR4-MyD88 signaling pathway in nigrostriatum of
LPS-stimulated mice
Whether myricitrin exerted anti-neuroinflammatory effects associate with regulating HMGB1, TLR4, MyD88? To answer this question, the expression of HMGB1, TLR4 and MyD88 were determined both at at protein level and mRNA level. Fig. 6A , 6B, and 6C showed that protein levels of HMGB1, TLR4 and MyD88
J o u r n a l P r e -p r o o f 9 in nigrostriatum of LPS-stimulated mice were all higher than that of in normal control group. Then we detected the mRNA level of HMGB1, TLR4 and MyD88 in nigrostriatum of LPS-stimulated mice were all higher than that of in normal control group (Fig. 6D, 6E and 6F). However, myricitrin treatment at the doses of 20 mg/kg and 50 mg/kg significantly suppressed HMGB1, TLR4 and MyD88 expression both at protein level and at mRNA level. These results indicate that myricitrin is likely to exert anti-neuroinflammatory effects via down-regulating TLR4/MyD88 pathway.
Myricitrin inhibited the phosphorylation of NF-κB signaling pathway in nigrostriatum of LPS-stimulated mice
The activation of NF-κB signaling pathway is involved in LPS-stimulated inflammation process. Next, we detected the expression of NF-κB p65, phospho-NF-κB p65, IκBα and phospho-IκBα by western blot. Results indicated that the expression of phospho-NF-κB p65 (Fig. 7A , p < 0.05) and phospho-IκBα (Fig. 7C , p < 0.01) were increased after LPS application. And the ratios of p-p65/p65 (Fig. 7B , p < 0.01) and p-IκBα/IκBα (Fig. 7D , p < 0.01) were significantly higher than that of control group. While myricitrin treatment inhibited the expression of phospho-NF-κB p65 and phospho-IκBα, which suggested that myricitrin alleviated LPS-induced neuroinflammation in nigrostriatum of mice by inhibiting the activation of NF-κB signaling pathway.
Myricitrin suppressed translocation of NF-κ B in nigrostriatum of
LPS-stimulated mice
In addition to the phosphorylation of NF-κB signaling pathway, the NF-κB nuclear translocation was further investigated. The results showed that the level of NF-κB p65
in nucleus was significantly increased in nigrostriatum of LPS-stimulated mice (Fig.   8A , p < 0.01), but there was no significant difference in cytoplasm (Fig. 8B ).
However, myricitrin treatment at doses of 20 mg/kg and 50 mg/kg both suppressed NF-κB nuclear translocation to nucleus (Fig. 8A , both p < 0.01). These results J o u r n a l P r e -p r o o f 10 indicates that myricitrin is a negative mediator of LPS-activated NF-κB nuclear translocation in nigrostriatum of LPS-stimulated mice.
Myricitrin down-regulated phosphorylation of p38, ERK and JNK in nigrostriatum of LPS-stimulated mice
Activation of MAPK signaling pathways leads to the expression of inflammatory factors and promotes inflammatory processes. Therefore, MAPK signaling pathways are considered to be crucial mechanisms in controlling inflammatory activity. To elucidate the mechanism of anti-inflammatory action of myricitrin in MAPK signaling pathway, the expression of ERK, p-ERK, JNK, p-JNK, p38, and p-p38 were further determined by western blot assay. As shown in Fig. 9A , 9C, and 9E, LPS upregulated the phosphorylation of the p38 , JNK and ERK in the nigrostriatum of LSP-stimulated mice (p < 0.01, p < 0.01, p < 0.05, respectively). In addition, the ratios of p-p38 to p38 (Fig. 9B ), p-ERK to ERK (Fig. 9D) , and p-JNK to JNK (Fig. 9F ) were all significantly increased in nigrostriatum of LPS-stimulated mice compared to control group (p < 0.01, p < 0.01, p < 0.05, respectively). However, myricitrin treatment at the doses of 20 and 50 mg/kg significantly suppressed the phosphorylation of p38, ERK and JNK.
Discussion
In the present study, we investigated the anti-neuroinflammation of myricitrin and explored the mechanism. Our study found that myricitrin has a potential anti-neuroinflammation in the nigrostriatum of LPS-stimulated mice. Meanwhile, we firstly found that myricitrin exerts anti-neuroinflammation associated with inhibiting TLR4/MyD88 pathway, blocking activation of NF-κB and phosphorylation of MAPKs.
NeuN is expressed in nucleus and cell body of most neurons and not in glial cells, oligodendrocytes, astrocytes, or microglial cells [Wolf et al., 1996] PD is a common central nervous system degenerative disease in the elderly, with pathological changes in the nigrostriatal DA neurons [Schneider et al. , 2017] .TH participates in the synthesis of dopamine and catalyzes the conversion of tyrosine to the precursor of DA [Tekin et al. , 2014] . The reduction of TH in the nigrostriatal DA region is a characteristic change in PD [Johnson et al. , 2019] . Recent studies have confirmed that the expression of TH in mouse brain is significantly reduced after stimulation with LPS in mice during puberty, while mice show Parkinson-like behavior [Wang et al., 2010] . Consistent with previous study, we also found LPS decreased the expression of TH in this study. Furthermore, myricitrin treatment improved TH expression in nigrostriatum of LPS-stimulated mice. This indicated that myricitrin has a protective effect on nigrostriatum and improves the decrease of DA after brain injury. Therefore, it is speculated that myricitrin may play a role in the treatment of PD, but the effect of myricitrin on the level of DA and its metabolites still need to be further explored in future research.
PSD-95 is a member of the membrane-associated guanylate kinase family and is involved in pathophysiological processes through interaction with membrane proteins.
In recent years, more and more studies have found that PSD-95 is closely related to neurodegenerative diseases and cerebral ischemia injury [Wang et al., 2010] . Recent studies have shown that synaptic proteins are closely related to learning and memory functions, and excessive loss of synaptic proteins may cause cognitive impairment [Zong et al. , 2019] . Our results showed that the expression of PSD-95 in the nigrostriatum was significantly decreased in nigrostriatum of LPS-stimulated mice, J o u r n a l P r e -p r o o f whereas myricitrin treatment improved PSD-95 expression. These results indicated that myricitrin exerts neuroprotetion by improving synaptic density in nigrostriatum of LPS-stimulated mice.
Accumulating evidence has demonstrated that neuroinflammation plays an important role in the progression of neurodegenerative diseases [Niranjan et al., 2018] .
It is currently believed that characteristic of neuroinflammation are glial cell activation, destruction of the blood-brain barrier, and peripheral immune cells entering the brain parenchyma [Tsui et al., 2018] . Our data showed that LPS promoted the release of inflammatory cytokines, such as IL-1β, IL-6, TNF-α, MCP-1, COX-2 and iNOS, in the nigrostriatum of LPS-stimulated mice. It is to be noted that from our experiment myricitrin could suppress the levels of these inflammatory factors in nigrostriatum of LPS-stimulated mice. These data indicated that myricitrin can protect the nigrostriatum from neuroinflammation injury.
HMGB1, a non-histone chromatin-binding protein, is widely involved in various inflammatory reactions and is related to many CNS diseases, including stroke, traumatic brain injury, PD, AD and epilepsy [Nishibori, 2018; Nishibori et al. , 2019] .
Studies have demonstrated that inhibition of HMGB1 helps to reduce neuroinflammation and improve BBB destruction in PD [Sasaki et al. , 2016] . It is reported that LPS increased expression of HMGB1 in brain tissue, and participated in LPS-induced neuroinflammatory processes [Cheng et al., 2018; Li et al., 2013; . Consistent with previous studies, our results also showed that the expression of HMGB1 in the nigrostriatum of mice was increased after LPS challenge.
And as expected, myricitrin downregulated the level of HMGB1. HMGB1 and LPS can bind to TLR4 with the dimerization and upregulating of MyD88, which can trigger and promote the downstream signal transduction, such as NF-κB, MAPKs pathway [Sasimol et al., 2018; Wu et al., 2018] . In our results, we also found that LPS increased the level of TLR4 and MyD88 and myricitrin can down-regulate the expressions of TLR4 and MyD88.
J o u r n a l P r e -p r o o f NF-κB, a family of transcription factors, have the effect on regulation of inflammatory response [Vallabhapurapu et al., 2009] . In general, NF-κB is sequestered by inhibitors of κB (IκB) in the cytoplasm in resting cells. Once receiving stimuli, such as LPS, NF-κB was release from IκB and translocated from cytoplasm into nucleus to promote the transcription of downstrea m genes [Nepali et al., 2017] .
NF-κB is known to play a vital role in the mediation of immune and inflammatory responses [Zhang & Ghosh, 2001] . Under normal conditions, the NF-κB dimers p50
and p65 exist in the cytoplasm in a complex with the inhibitor protein IκB. When IκB is activated, it is phosphorylated and then ubiquitinated, leading to its degradation.
Subsequently, the free NF-κB dimer translocates to the nucleus and promoting the transcription of various pro-inflammatory enzymes [Mercurio & Manning, 1999; Ghosh & Hayden, 2008; Lappas et al., 2002; Ren et al., 2019; Cai et al., 2018] . Many studies have found that inhibition of NF-ĸB pathway can effectively reduce LPS-induced inflammation [Fu et al., 2018; Ding et al., 2018] . In this study, we also found that the expression of phosphorylated IκB and NF-κB were remarkably upregulated in LPS-stimulated group, which are consistent with previous studies.
However, myricitrin revealed concentration-dependent suppression of phosphorylation of IκB and NF-κB. And we found that myricitrin exerts anti-inflammatory effects mainly by affecting the translocation and phosphorylation of NF-κB pathway. In a conclusion, the anti-inflammatory mechanism of myricitrin is likely related to inhibition of NF-κB pathway.
MAPKs are intracellular serine/threonine protein kinases that consist of extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun NH2-terminal kinase (JNK) [Reibman et al., 2000] . MAPKs are a major family of kinases associated with the inflammation process [Pearson et al., 2001; Yu et al., 2018] . Many stress stimuli can activate MAPKs like ionizing radiation, cytokines and growth factors [Zhang et al., 2017] . Moreover, lipopolysaccharide (LPS) can activate MAPKs, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. These proteins then modulate cytokine production and the expression J o u r n a l P r e -p r o o f 14 of pro-inflammatory enzymes, such as NF-κB, iNOS, COX-2, TNF-α, and IL-1β [Rao, 2001; Rajapakse et al., 2008] . In this study, our results showed that LPS activated the MAPKs proteins, such as p38, ERK, and JNK. However, myricitrin can reversed the activation of p38, ERK and JNK induced by LPS. But there are many downstream targets of the MAPK pathways, and the role of myricitrin for its downstream targets still needs further exploration and confirmation.
In conclusion, our studies found myricitrin protects nigrostriatum neuron in LPS-stimulated mice, which is associated with its anti-neuroinflammtion via blocking the activation of NF-κB and MAPKs signaling pathways. It is speculated that myricitrin is beneficial to treatment of PD for its anti-neuroinflammation in nigrostriatum. Our investigation will enrich the pharmacological effects of myricitrin, expand the scope of clinical application, and provide new idea for neuroprotion and anti-neuroinflammation treatment in PD. However, in this experiment, we preliminarily observed whether myricetin plays role s in the NF-κB and MAPKs signaling pathways and there is a lack of in-depth study about these signaling pathways. In-depth study in the future, different specific inhibitors (e.g., p38, JNK, ERK, NF-κB inhibitors) will be used to further explore the mechanism of myricitin.
J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f  Myricitrin has anti-neuroinflammation potential.
 Myricitrin protects nigrostriatum neuron in LPS-stimulated mice and is beneficial to the treatment of nigrostriatum inflammation.
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